CECC explains its plan to require non-R.O.C. nationals without NHI cards who are diagnosed with COVID-19 in Taiwan to pay their medical costs during their isolation period themselves starting January 1, 2023

On December 5, the Central Epidemic Command Center (CECC) announced that, in consideration of a steady increase in the number of inbound travelers, it plans to adjust the eligibility criteria for the government's program to cover the medical expenses of people diagnosed with COVID-19 during their isolation period (based on the nationality/National Health Insurance status at the time of diagnosis). The adjustments about eligibility, which will take effect on January 1, 2023, are listed below.

A. The government will cover the medical expenses related to isolation and treatment of R.O.C. nationals (regardless of NHI status), non-R.O.C. nationals enrolled in the NHI program, and employed foreign nationals in Taiwan (including blue-collar foreign workers, white-collar foreign workers, missing foreign workers, and foreign fishermen employed by domestic entities) during their isolation period.

B. Non-R.O.C. nationals not enrolled in the NHI program should pay their medical expenses during their isolation period if they are diagnosed with COVID-19 in Taiwan.

source of press release：https://www.cdc.gov.tw/En/Bulletin/Detail/XkhPSHmVvpUvdEhHjwx8kw?typeid=158

中央流行疫情指揮中心今(5)日表示，考量國內疫情趨緩，邊境及社區防治政策穩健鬆綁，規劃自2023年1月1日起，
非本國籍人士在臺期間如確診COVID-19，其確診隔離治療費用須由確診者自付。

指揮中心指出，現行民眾於國內確診後隔離治療或隔離治療期間之相關醫療費用，不分國籍、或是否具健保身分，均由政府預算支應。
依據監測資料顯示，本(2022)年截至11月28日止，非本國籍人士確診個案數計260,929例，占本年確定病例數3.2%，其中112例為中、重症個案。

為因應入境旅客人數穩定成長，預計自2023年1月1日起(確診隔離起始日)，調整COVID-19確診隔離治療費用支付對象(以確診當下之身分別為主)：
一、具中華民國國籍者(不論是否具健保身分)、具健保身分之非本國籍人士以及在臺受聘僱之外籍人士(含藍領移工、白領應聘、失聯移工、境內僱用之外籍漁工等)，其確診隔離治療期間相關費用由政府預算支應。
二、不具健保身分之非本國籍人士如於在臺期間確診，其確診隔離治療期間相關費用由個案自行負擔。 指揮中心說明，請相關部會(外交部、內政部、教育部、交通部等)宣導不具健保身分之外籍人士(含旅客、短期來臺交換學生等)於入境前建議投保醫療險，
在臺期間應遵守現行防疫規範，外出時可攜帶乾洗手用品隨時保持手部清潔，返回住所時，確實執行手部衛生。如果出現發燒、呼吸道症狀、腹瀉或嗅、味覺異常時，應佩戴口罩，儘速就醫，不要搭乘大眾運輸工具及前往其他公共場所，確保防疫安全。

文字來源：衛生福利部疾病管制署：https://gov.tw/qr5